Mariner’s LifeMD LFMD Stock Holding History

Mariner’s Portfolio LFMD Stock Details LFMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-11,955	Closed	-$163K	–	3678
2025 Q2	$163K	Sell	11,955 -2,179	-15%	-$20.6K	﹤0.01%	3117
2025 Q1	$76.9K	Buy	14,134 +544	+4%	+$3.09K	﹤0.01%	3239
2024 Q4	$67.3K	Buy	+13,590	New	+$71.2K	﹤0.01%	3251

Other funds holding LFMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Mariner's LFMD Position: Q3 2025 in Review

Mariner sold out of LifeMD (LFMD) in Q3 2025, closing a stake of 11,955 shares — an estimated $163K sold.

Mariner first reported a position in LFMD in Q4 2024 and held it in 3 quarters. The position peaked at $163K in Q2 2025. 114 funds tracked by Wall St. Rank hold LFMD as of Q3 2025.

Mariner reported no remaining LifeMD position as of Q3 2025 after selling out during the quarter.
Mariner sold 11,955 LifeMD shares in Q3 2025, an estimated $163K.
Mariner first reported a position in LifeMD in Q4 2024 and held it in 3 quarters.
Mariner's LifeMD position peaked at $163K in Q2 2025.
114 funds tracked by Wall St. Rank held LifeMD as of Q3 2025.

Based on Mariner's 13F filing for Q3 2025, filed 14 Nov 2025.